• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Int J Infect Dis . Temporal and age distributions of SARS-CoV-2 and other coronaviruses, Southeastern France

tetano

Editor, Senior Moderator
Int J Infect Dis


. 2020 Sep 22;S1201-9712(20)32133-0.
doi: 10.1016/j.ijid.2020.09.1417. Online ahead of print.
Temporal and age distributions of SARS-CoV-2 and other coronaviruses, Southeastern France


Philippe Colson[SUP] 1 [/SUP], Vera Esteves-Vieira[SUP] 2 [/SUP], Audrey Giraud-Gatineau[SUP] 3 [/SUP], Christine Zandotti[SUP] 2 [/SUP], V?ronique Filosa[SUP] 2 [/SUP], Herv? Chaudet[SUP] 3 [/SUP], Jean-Christophe Lagier[SUP] 1 [/SUP], Didier Raoult[SUP] 4 [/SUP]



Affiliations

Abstract

Objectives: The SARS-CoV-2 epidemic presents a poorly understood epidemiological cycle. We aimed to compare the age and weekly distribution of the five human coronaviruses, including SARS-CoV-2 that circulated in southeastern France.
Methods: We analyzed all available diagnoses of respiratory viruses including SARS-CoV-2 performed between 09/2013 and 05/2020 at University Hospital Institute M?diterran?e Infection in Marseille, Southeastern France.
Results: For SARS-CoV-2, positive children <15 years of age represented 3.4% (228/6,735) of all positive cases, which is significantly less than for endemic coronaviruses (46.1%; 533/1,156; p < 0.001). Among 10,026 patients tested for SARS-CoV-2 and endemic coronaviruses in 2020, children <15 years represented a significantly lower proportion of all positive cases for SARS-CoV-2 than for endemic coronaviruses [2.2% (24/1,067) vs 33.5% (149/445), respectively; p < 0.001]. Epidemic curves for endemic coronaviruses and SARS-CoV-2 in 91,722 patients showed comparable bell-shaped distributions with a slight time lag. In contrast, age distribution of endemic coronaviruses and 14 other respiratory viruses differed very significantly compared to that of SARS-CoV2, which was the only virus to spare children.
Conclusions: Thus, we observed for SARS-CoV-2 a temporal distribution resembling that of endemic coronaviruses and an age distribution that spares the youngest subjects who are those the most exposed to endemic coronaviruses.

Keywords: SARS-CoV-2; Southeastern France; age; children; cross-immunity; endemic coronavirus.
 
Back
Top Bottom